Dividend-paying stocks are a traditional defensive play, while healthcare faces fewer trade and economic headwinds than most ...

The FDA has approved a new triple-drug antibiotic from Merck & Co, but the company and regulator have cautioned it should only be prescribed for last-ditch use. Recarbrio – which based on ...

Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating ...

Forward-Looking Statement of Merck & Co., Inc., Rahway ... the impact of pharmaceutical industry regulation and health care legislation in the United States and internationally; global trends ...

According to the company, the new, 225,000-square-foot expansion is a "crucial component" of a more than $12 billion infusion ...

Why do we care about what ... (see more details here). Merck & Co., Inc. (NYSE:MRK) is a global healthcare company with two segments: pharmaceutical and Animal Health. Over the last six months ...

Li, executive vice president and president, Merck Research Laboratories, are scheduled to participate in a fireside chat at the TD Cowen 45th Annual Health Care Conference on Monday, March 3 ...